Poolbeg Pharma PLC (AIM:POLB)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 6.44
+0.04 (0.63%)
Nov 4, 2026, 2:55 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 49.17 million as of November 4, 2026. It is the 28,057th most valuable company in the world and the 626th biggest in the United Kingdom. Its market cap has increased by 83.16% in one year.
Market Cap
49.17M
Enterprise Value
44.35M
Revenue
n/a
Global Rank
Country Rank
#626 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 49.17M, a decrease of -8.53%. That is a compound annual growth rate of -1.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 49.17M | 76.30% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bioventix | 105.75M |
| Scancell Holdings | 104.92M |
| 4basebio | 82.35M |
| Faron Pharmaceuticals Oy | 65.06M |
| Ondine Biomedical | 54.72M |
| Hemogenyx Pharmaceuticals | 39.08M |
| Arecor Therapeutics | 38.51M |
| IXICO | 36.13M |